Fuan Pharmaceutical Group Co (300194.SZ) stock: key figures, P/E, revenue and dividend
Health Care · Pharmaceuticals · China · ISIN CNE1000011G4
Fuan Pharmaceutical Group Co financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 2.39 bn CNY | 1.74 bn CNY |
| Gross profit | 1.22 bn CNY | 642.58 m CNY |
| Operating income | 320.85 m CNY | 96.38 m CNY |
| EBIT | 336.05 m CNY | 105.40 m CNY |
| Net income | 279.84 m CNY | 77.00 m CNY |
| Diluted EPS – continuing operations | 0.24 CNY | 0.06 CNY |
Full history since 2007, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Fuan Pharmaceutical Group Co
Fuan Pharmaceutical (Group) Co., Ltd., together with its subsidiaries, research and develops, produces, and sells chemical drugs in the People's Republic of China and internationally. It offers APIs; intermediates; and FDFs, such as anti-tumor, specialty drugs, antibiotics, as well as freeze-drying preparation for injection. The company was formerly known as Chongqing Fuan Pharmaceutical (Group) Co., Ltd. and changed its name to Fuan Pharmaceutical (Group) Co., Ltd. in August 2013. The company was founded in 2004 and is headquartered in Chongqing, the People's Republic of China.
More stocks
- Public Property Invest ASA (PUBLI.OL)
- Zhongjie (Jiangsu) Technology Co.Ltd. (301072.SZ)
- i3 Verticals, Inc. (IIIV)
- Annexon, Inc. (ANNX)
- Silex Systems Ltd (SLX.AX)
- Feitian Technologies Co Ltd (300386.SZ)
- PVA TePla (TPE.DE)
- SMITH & WESSON BRANDS, INC. (SWBI)
- PAPA JOHNS INTERNATIONAL INC (PZZA)
- Xiamen Comfort Science&Technology Group Co Ltd (002614.SZ)
- Patrizia (PAT.DE)
- Carlton Investments Ltd (CIN.AX)
Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.